Dual Immunotherapy: Balancing Efficacy Vs. Toxicity
Details
The IASCC Dual Immunotherapy Meeting is a focused scientific forum dedicated to exploring the rapidly evolving role of dual immunotherapy in contemporary cancer care. The meeting will bring together oncology experts and healthcare professionals to discuss advances in immune-based treatment approaches, emerging clinical evidence, and practical considerations in patient management.
With the increasing use of immunotherapy across multiple cancer types, understanding the optimal application of combination immune therapies and strategies to improve patient outcomes has become essential. The meeting will provide a platform for expert-led discussions on treatment approaches, patient selection, clinical decision-making, and management of immune-related adverse events. The program will also highlight the importance of integrating supportive care to address treatment-related toxicities and ensure comprehensive, patient-centered cancer care.
Through multidisciplinary discussions and knowledge exchange, the meeting aims to promote evidence-based practice, enhance clinical understanding, and strengthen collaborative approaches in the evolving landscape of immuno-oncology.